Sort   by:  
 Page size 
UnknownImmune persistence and safety of the AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50-59 years of age, including at-increased-risk adults: A randomized controlled trial.
Not available
S-EPMC12599337 | biostudies-literature
UnknownNoninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to ≥60 Years of Age.
Not available
S-EPMC11478578 | biostudies-literature
Sort   by:  
 Page size